Eli Lilly

Eli Lilly became one of the world's most valuable companies on the back of a single class of drug. Its GLP-1 medicines, sold as Mounjaro for diabetes and Zepbound for weight loss, put it at the front of the obesity-treatment boom alongside Novo Nordisk, and demand has run so far ahead of supply that the company is spending billions to build new plants. Diabetes and obesity are the headline, but Lilly also sells drugs for cancer, immune conditions and Alzheimer's, giving it a deep pipeline behind the blockbusters. Founded in 1876 by a Civil War veteran and pharmacist, and still based in Indianapolis, Indiana, it is one of the oldest pharmaceutical firms in America. The stock trades at a premium that assumes the weight-loss franchise keeps expanding into a vast market, so any stumble on trials, pricing or manufacturing tends to hit it hard.

On MyRWA, LLY trades tokenized across 33 on-chain venues - see the listings below.